These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 18403938)
1. The biochemical and clinical penetrance of individuals diagnosed with genetic haemochromatosis by predictive genetic testing. Watkins S; Thorburn D; Joshi N; Neilson M; Joyce T; Spooner R; Cooke A; Mills PR; Morris AJ; Stanley AJ Eur J Gastroenterol Hepatol; 2008 May; 20(5):379-83. PubMed ID: 18403938 [TBL] [Abstract][Full Text] [Related]
2. [Molecular genetic diagnostics and screening of hereditary hemochromatosis]. Zlocha J; Kovács L; Pozgayová S; Kupcová V; Durínová S Vnitr Lek; 2006 Jun; 52(6):602-8. PubMed ID: 16871764 [TBL] [Abstract][Full Text] [Related]
3. Clinical expression of haemochromatosis in Irish C282Y homozygotes identified through family screening. Gleeson F; Ryan E; Barrett S; Crowe J Eur J Gastroenterol Hepatol; 2004 Sep; 16(9):859-63. PubMed ID: 15316409 [TBL] [Abstract][Full Text] [Related]
4. Correlation between iron status and genetic hemochromatosis (codon C282Y) in a large German population. Wrede CE; Hutzler S; Bollheimer LC; Buettner R; Hellerbrand C; Schöelmerich J; Palitzsch KD Isr Med Assoc J; 2004 Jan; 6(1):30-3. PubMed ID: 14740507 [TBL] [Abstract][Full Text] [Related]
5. Iron-overload-related disease in HFE hereditary hemochromatosis. Allen KJ; Gurrin LC; Constantine CC; Osborne NJ; Delatycki MB; Nicoll AJ; McLaren CE; Bahlo M; Nisselle AE; Vulpe CD; Anderson GJ; Southey MC; Giles GG; English DR; Hopper JL; Olynyk JK; Powell LW; Gertig DM N Engl J Med; 2008 Jan; 358(3):221-30. PubMed ID: 18199861 [TBL] [Abstract][Full Text] [Related]
6. Reverse cascade screening of newborns for hereditary haemochromatosis: a model for other late onset diseases? Cadet E; Capron D; Gallet M; Omanga-Léké ML; Boutignon H; Julier C; Robson KJ; Rochette J J Med Genet; 2005 May; 42(5):390-5. PubMed ID: 15863667 [TBL] [Abstract][Full Text] [Related]
7. Correlation between genotype and phenotype in hereditary hemochromatosis: analysis of 61 cases. Sham RL; Ou CY; Cappuccio J; Braggins C; Dunnigan K; Phatak PD Blood Cells Mol Dis; 1997 Aug; 23(2):314-20. PubMed ID: 9410475 [TBL] [Abstract][Full Text] [Related]
8. Underdiagnosis of hereditary haemochromatosis: lack of presentation or penetration? Ryan E; Byrnes V; Coughlan B; Flanagan AM; Barrett S; O'Keane JC; Crowe J Gut; 2002 Jul; 51(1):108-12. PubMed ID: 12077102 [TBL] [Abstract][Full Text] [Related]
9. Hemochromatosis and iron-overload screening in a racially diverse population. Adams PC; Reboussin DM; Barton JC; McLaren CE; Eckfeldt JH; McLaren GD; Dawkins FW; Acton RT; Harris EL; Gordeuk VR; Leiendecker-Foster C; Speechley M; Snively BM; Holup JL; Thomson E; Sholinsky P; N Engl J Med; 2005 Apr; 352(17):1769-78. PubMed ID: 15858186 [TBL] [Abstract][Full Text] [Related]
10. Hereditary hemochromatosis in a Brazilian university hospital in São Paulo State (1990-2000). Martinelli AL; Filho R; Cruz S; Franco R; Tavella M; Secaf M; Ramalho L; Zucoloto S; Rodrigues S; Zago M Genet Mol Res; 2005 Mar; 4(1):31-8. PubMed ID: 15841433 [TBL] [Abstract][Full Text] [Related]
11. HFE genotype and parameters of iron metabolism in German first-time blood donors - evidence for an increased transferrin saturation in C282Y heterozygotes. Raddatz D; Legler T; Lynen R; Addicks N; Ramadori G Z Gastroenterol; 2003 Nov; 41(11):1069-76. PubMed ID: 14648375 [TBL] [Abstract][Full Text] [Related]
12. Mutations of the hemochromatosis gene in Italian candidate blood donors with increased transferrin saturation. Velati C; Marlianici E; Rigamonti D; Barillari G; Chiavilli F; Fugiani P; Garozzo G; Lancieri M; Rinaldi S; Testa D; Sampietro M; Tavazzi D; Delbini P; Fargion S; Fiorelli G Hematol J; 2003; 4(6):436-40. PubMed ID: 14671617 [TBL] [Abstract][Full Text] [Related]
13. Transferrin receptor-2 gene and non-C282Y homozygous patients with hemochromatosis. Aguilar-Martinez P; Esculié-Coste C; Bismuth M; Giansily-Blaizot M; Larrey D; Schved JF Blood Cells Mol Dis; 2001; 27(1):290-3. PubMed ID: 11358390 [TBL] [Abstract][Full Text] [Related]
14. The clinical relevance of compound heterozygosity for the C282Y and H63D substitutions in hemochromatosis. Walsh A; Dixon JL; Ramm GA; Hewett DG; Lincoln DJ; Anderson GJ; Subramaniam VN; Dodemaide J; Cavanaugh JA; Bassett ML; Powell LW Clin Gastroenterol Hepatol; 2006 Nov; 4(11):1403-10. PubMed ID: 16979952 [TBL] [Abstract][Full Text] [Related]
15. Elevated MCP-1 serum levels are associated with the H63D mutation and not the C282Y mutation in hereditary hemochromatosis. Lawless MW; White M; Mankan AK; O'Dwyer MJ; Norris S Tissue Antigens; 2007 Oct; 70(4):294-300. PubMed ID: 17767550 [TBL] [Abstract][Full Text] [Related]
16. A population-based study of the clinical expression of the hemochromatosis gene. Olynyk JK; Cullen DJ; Aquilia S; Rossi E; Summerville L; Powell LW N Engl J Med; 1999 Sep; 341(10):718-24. PubMed ID: 10471457 [TBL] [Abstract][Full Text] [Related]
17. HFE mutations, hepatic iron, and fibrosis: ethnic-specific association of NASH with C282Y but not with fibrotic severity. Chitturi S; Weltman M; Farrell GC; McDonald D; Kench J; Liddle C; Samarasinghe D; Lin R; Abeygunasekera S; George J Hepatology; 2002 Jul; 36(1):142-9. PubMed ID: 12085358 [TBL] [Abstract][Full Text] [Related]